483
Hai Shao, M.D.FDA 483 - Hai Shao, M.D. - July 15, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Hai Shao, M.D., a clinical investigator in Chula Vista, CA, revealed significant deficiencies in the conduct of a clinical investigation. Observations included failures to adhere to the investigational plan by not performing required subject procedures and inadequate documentation of informed consent and adverse events in case histories. These issues indicate a lack of proper oversight and record-keeping during the clinical trial.
Open in Dashboard
ID · 9ca6595c-6721-4bfd-a748-654ccf849e1f